Tumor Thrombus on 18F-FDG PET/CT in Stage IV Plasmablastic Lymphoma

被引:0
|
作者
Jacquet, Thibaut [1 ,2 ]
Huchet, Virginie [1 ,2 ]
Bedoui, Manel [1 ,2 ]
Jehanno, Nina [1 ,2 ]
机构
[1] Inst Curie, Dept Nucl Med, Paris, France
[2] Inst Curie, Dept Hematol, 26 Rue Ulm, F-75005 Paris, France
关键词
tumor thrombus; PET/CT; F-18-FDG; plasmablastic lymphoma; DIAGNOSIS; CT;
D O I
10.1097/RLU.0000000000003822
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 71-year-old woman with a history of back pain and recent weight loss presented to the emergency department with hematuria. A CT scan was performed and showed left retroperitoneal mass with left renal vein thrombus extended to the vena cava. Tumor biopsy revealed plasmablastic lymphoma. Staging with 18F-FDG PET/CT scan was performed and revealed pulmonary, hepatic, and left supraclavicular lymph node extension. The left retroperitoneal mass showed intense FDG uptake and was associated with widespread tumor thrombus in the peripheral abdominal veins. Differentiating tumor thrombus from bland thrombosis has a significant impact on patient's management. © 2021 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:E140 / E141
页数:2
相关论文
共 50 条
  • [31] Application of 18F-FDG PET/CT in primary thyroid lymphoma
    Fan, Yang
    Yang, Zhi
    Wang, Xuejuan
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [32] 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter
    He, Limeng
    Deng, Yujiao
    Deng, Ying
    Xie, Hongjun
    Zhang, Wei
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (09) : 828 - 829
  • [33] 18F-FDG PET/CT in the evaluation of parotideal MALT lymphoma
    Castellucci, P
    Nanni, C
    Farsad, M
    Alinari, L
    Stefoni, V
    Magagnoli, G
    Santagata, F
    Levorato, M
    Pettinato, C
    Marengo, M
    Boschi, S
    Zinzani, PL
    Franchi, R
    Fanti, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S337 - S337
  • [34] The clinical impact of 18F-FDG PET/CT in Hodgkin lymphoma
    Molnar, Z.
    Deak, B.
    Lengyel, Z.
    Molnar, P.
    Rosta, A.
    Schneider, T.
    Szaleczky, E.
    Varga, F.
    Varady, E.
    Borbely, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S434 - S434
  • [35] The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma
    Qiu, Lin
    Chen, Yue
    Wu, Jingbo
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2013, 16 (03): : 230 - 236
  • [36] The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT
    Nagamachi, Shigeki
    Nishii, Ryuichi
    Wakamatsu, Hideyuki
    Mizutani, Youichi
    Kiyohara, Shogo
    Fujita, Seigo
    Futami, Shigemi
    Sakae, Tatefumi
    Furukoji, Eiji
    Tamura, Shozo
    Arita, Hideo
    Chijiiwa, Kazuo
    Kawai, Keiichi
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (06) : 554 - 563
  • [37] The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT
    Shigeki Nagamachi
    Ryuichi Nishii
    Hideyuki Wakamatsu
    Youichi Mizutani
    Shogo Kiyohara
    Seigo Fujita
    Shigemi Futami
    Tatefumi Sakae
    Eiji Furukoji
    Shozo Tamura
    Hideo Arita
    Kazuo Chijiiwa
    Keiichi Kawai
    Annals of Nuclear Medicine, 2013, 27 : 554 - 563
  • [38] The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma
    Qiu, Lin
    Tu, Guojian
    Li, Jing
    Chen, Yue
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (02) : 106 - 116
  • [39] Incidental finding of an endobronchial tumor by 18F-FDG PET/CT
    Navales, I.
    Garcia, J. R.
    Alvarez-Moro, F. J.
    Navarro, A.
    Escobar, I.
    Lomena, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (04): : 271 - 272
  • [40] MRI and 18F-FDG PET/CT of Laryngeal Cartilaginous Tumor
    Nakagawa, Junichi
    Manabe, Osamu
    Mizumachi, Takatsugu
    Kanno-Okada, Hiromi
    Hatanaka, Kanako C.
    Mitsuhashi, Tomoko
    Oyama-Manabe, Noriko
    Hirata, Kenji
    Tamaki, Nagara
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : E157 - E160